CD8A and neoplasm: These results highlight superior quality of the T cells induced by the CRX-527 conjugates, which translates into superior control of aggressive tumor growth, and underline the importance of combining CD4 and CD8 conjugate vaccines for optimal induction of functional T cell responses.